Publications by authors named "Samuel Kulp"

Claim this Profile
O
OSU-ERβ-12: a promising pre-clinical candidate selective estrogen receptor beta agonist.
Gregory M Young, Timothy H Helms, Samuel K Kulp, Adeoluwa A Adeluola, Hanna S Radomska

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma.
Emma J Hoelzen, Hanna S Radomska, Samuel K Kulp, Adeoluwa A Adeluola, Lauren A Granchie

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility.
Hanieh Taheri, Yang Li, Kevin M Huang, Eman Ahmed, Yan Jin, Samuel K Kulp

Cancer Res Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J Mice.
Bryan C Remaily, Trang T Vu, Justin Thomas, Kyeongmin Kim, Camille Stanton, Samuel K Kulp

JCSM Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonists.
Adeoluwa A Adeluola, Hanna S Radomska, Tyler A Wilson, Samuel K Kulp, Alyssa Kabat

J Pharmacol Exp Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors.
Yizhen Guo, Bryan C Remaily, Justin Thomas, Kyeongmin Kim, Samuel K Kulp

Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia.
Trang T Vu, Kyeongmin Kim, Millennium Manna, Justin Thomas, Bryan C Remaily, Samuel K Kulp

Pharmacol Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models.
Elizabeth N Kaweesa, Jaqueline M Bazioli, Herma C Pierre, Daniel D Lantvit, Samuel K Kulp

Mol Pharm· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.
Yizhen Guo, Lai Wei, Sandip H Patel, Gabrielle Lopez, Madison Grogan, Samuel K Kulp

Clin Lung Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer.
Justin Thomas, Molly A Torok, Kriti Agrawal, Timothy Pfau, Trang T Vu, Samuel K Kulp

Int J Mol Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition.
Pu Zhang, Lindsey T Brinton, Katie Williams, Steven Sher, Shelley Orwick, Samuel K Kulp

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Timothy H Helms, Riley D Mullins, Jennifer M Thomas-Ahner, Samuel K Kulp, Moray J Campbell

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans.
Alyssa Marie M Castillo, Trang T Vu, Sophia G Liva, Min Chen, Zhiliang Xie, Samuel K Kulp

JCSM Rapid Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soy-tomato enriched diet reduces inflammation and disease severity in a pre-clinical model of chronic pancreatitis.
Debasmita Mukherjee, Mallory J DiVincenzo, Molly Torok, Fouad Choueiry, Rahul J Kumar, Samuel K Kulp

Sci Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Tolerability of the Novel Non-immunosuppressive Fingolimod Derivative, OSU-2S, in Dogs and Comparisons with Data in Mice and Rats.
Zhiliang Xie, Min Chen, Swagata Goswami, Rajes Mani, Dasheng Wang, Samuel K Kulp

AAPS J· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.
Min-Wu Chao, Po-Chen Chu, Hsiao-Ching Chuang, Fang-Hsiu Shen, Chih-Chien Chou, Samuel K Kulp

Oncotarget· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor.
Sophia G Liva, Yu-Chou Tseng, Anees M Dauki, Michael G Sovic, Trang Vu, Samuel K Kulp

EMBO Mol Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Antitumor Effects of a Novel Phenylbutyrate-based Histone Deacetylase Inhibitor, ()-HDAC-42, in Prostate Cancer.
Samuel K Kulp, Chang-Shi Chen, Da-Sheng Wang, Ching-Yu Chen, Ching-Shih Chen

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors.
Jiuxiang Zhu, Jui-Wen Huang, Ping-Hui Tseng, Ya-Ting Yang, Joseph Fowble, Samuel K Kulp

Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Sensitizing Estrogen Receptor-negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor.
Shu-Chuan Weng, Yoko Kashida, Samuel K Kulp, Dasheng Wang, Robert W Brueggemeier

Mol Cancer Ther· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.
Po-Chen Chu, Samuel K Kulp, Ching-Shih Chen

Carcinogenesis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Corrigendum: Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.
Po-Chen Chu, Samuel K Kulp, Ching-Shih Chen

Carcinogenesis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion.
Chunwan Lu, Dafeng Yang, John D Klement, Il Kyu Oh, Natasha M Savage, Samuel K Kulp

Cancer Immunol Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction of "Development of Novel Adenosine Monophosphate-Activated Protein Kinase Activators".
Jih-Hwa Guh, Wei-Ling Chang, Jian Yang, Su-Lin Lee, Shuo Wei, Samuel K Kulp

J Med Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction of "Development of a Novel Class of Glucose Transporter Inhibitors".
Dasheng Wang, Po-Chen Chu, Chia-Ning Yang, Ribai Yan, Yu-Chung Chuang, Samuel K Kulp

J Med Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis